Intech Investment Management LLC Purchases Shares of 12,157 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Intech Investment Management LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,157 shares of the pharmacy operator’s stock, valued at approximately $109,000.

A number of other institutional investors have also made changes to their positions in WBA. Thompson Siegel & Walmsley LLC lifted its position in shares of Walgreens Boots Alliance by 98.8% during the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after purchasing an additional 2,992,648 shares in the last quarter. Newport Trust Company LLC acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth $31,028,000. Philip James Wealth Mangement LLC acquired a new position in shares of Walgreens Boots Alliance during the third quarter worth $5,252,000. Neo Ivy Capital Management acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth $6,642,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Walgreens Boots Alliance during the third quarter worth $3,448,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $8.56 on Friday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05. The company has a market cap of $7.40 billion, a price-to-earnings ratio of -0.86, a price-to-earnings-growth ratio of 1.15 and a beta of 0.66. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The firm has a fifty day moving average of $9.16 and a 200-day moving average of $10.93.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.67 earnings per share. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 11.68%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analyst Ratings Changes

A number of analysts recently issued reports on WBA shares. TD Cowen dropped their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. JPMorgan Chase & Co. dropped their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, August 30th. Royal Bank of Canada dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research note on Wednesday. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. Finally, Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.